Making plasma derived medicines available

Journal Title: Iranian Journal of Blood and Cancer - Year 2011, Vol 3, Issue 3

Abstract

Recent progress in past two decades in recombinant technology has created the opportunity of production of some of the plasma proteins including co -agulation factors using mammalian cell cultures. However, some limitations including productivity, costs and immunogenic risks have limited worldwide availability of these products. Therefore, fractionation of human plasma still remains as the main source of producing wide range of the therapeutic pro -teins. Plasma contains several therapeutically important proteins. Currently more than 25 of them are commercially available to treat life-threatening diseas -es. However, unfortunately due to very high cost of treatment with plasma-derived medicines, theses are not affordable for the patients living in devel-oping countries. Local production, importation and /or contract fractionation of locally produced plasma are among the available options for providing plasma derived medicines.

Authors and Affiliations

Abdol Majid Cheraghali

Keywords

Related Articles

Breast Cancer Associated with Dermatomyositis

Dermatomyositis (DM) is a rare idiopathic inflammatory myopathy with characteristic skin lesions. Case series have shown an association between dermatomyositis and malignancy. Malignancy has been found in 15-25% of the a...

Congenital Leukemia: A Case Report

This article has no abstract.

Comparative Study of Four Platelet-Rich Plasma Methods for Preparing Platelet Concentrates

Background: Platelet preparations have been used for a wide variety of clinical applications such as hemorrhage, tissue engineering and cellular therapy. Platelet concentrates can be prepared by the apheresis method or f...

Serum Lipid Profile Alterations in Acute Leukemia Before and After Chemotherapy

Background: Serum lipids abnormalities have been observed in various forms of cancers including acute leukemia. Investigators report decreased total cholesterol and HDL, and elevated triglyceride in leukemic patients. Li...

Immunoglobulin A Preparation from Human Pooled Plasma Using Plasma Fractionation and Ion Exchange Chromatography

Background: In this study we have prepared the IgA solution from normal human plasma using plasma fractionation and ion exchange chromatography. Materials and Methods: Using fractionation of plasma with cold ethanol (sta...

Download PDF file
  • EP ID EP370853
  • DOI -
  • Views 61
  • Downloads 0

How To Cite

Abdol Majid Cheraghali (2011). Making plasma derived medicines available. Iranian Journal of Blood and Cancer, 3(3), 121-129. https://europub.co.uk/articles/-A-370853